Effect of Airway Integrated Nasal Packing With Different Material
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01562691 |
Recruitment Status :
Completed
First Posted : March 26, 2012
Last Update Posted : March 26, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Postoperative Respiratory Complications Pain, Postoperative. | Procedure: Nasopore Procedure: airway integrated Nasopore Procedure: airway-integrated Vaseline gauze | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Comparison of Nasal Packing Methods:Nasal Packing Was Done With Nasopore@, Airway-integrated Nasopore@ and Airway-integrated Vaseline Gauze |
Study Start Date : | June 2009 |
Actual Primary Completion Date : | June 2011 |
Actual Study Completion Date : | December 2011 |

Arm | Intervention/treatment |
---|---|
Experimental: Nasopore only
Packing using nasopore without airway integrated
|
Procedure: Nasopore
Bilateral nasal packing using Nasopore without airway integrated |
Active Comparator: nasopore with airway integrated
packing using airway integrated nasopore
|
Procedure: airway integrated Nasopore
post nasoseptoplasty with nasal packing using airway integrated Nasopore |
Active Comparator: airway-integrated Vaseline gauze
Nasal packing using airway-integrated Vaseline gauze
|
Procedure: airway-integrated Vaseline gauze
post nasal septoplasty with packing using airway-integrated Vaseline gauze |
- oxyhemoglobin saturation by pulse oximetry, SpO2 [ Time Frame: SpO2 was measured 30 minutes before operation, ]SpO2 was measured 30 minutes before operation using O2 saturation monitor.
- change of SpO2 from baseline to 4 hours post-operation [ Time Frame: records of the SpO2 at 4 hours post-operation ]records of the SpO2 at 4 hours post-operation
- change of the SpO2 from baseline to 6 hours post-operation [ Time Frame: records of the SpO2 at 6 hours post-operation ]records of the SpO2 at 6 hours post-operation
- change of the SpO2 from baseline to 12 hours post-operation [ Time Frame: records of the SpO2 at 12 hours post-operation ]records of the SpO2 at 12 hours post-operation
- change of the SpO2 from baseline to 18 hours post-operation [ Time Frame: records of the SpO2 at 18 hours post-operation ]records of the SpO2 at 18 hours post-operation
- change of the SpO2 from baseline to 48 hours post-operation [ Time Frame: records of the SpO2 at 48 hours post-operation ]records of the SpO2 at 48 hours post-operation
- postoperation pain [ Time Frame: record of postoperation pain scale at 2 hous post operation ]record of postoperation pain scale at 2 hours post-operation
- change of postoperation pain scale from baseline to 4 hours post-operation [ Time Frame: record of postoperation pain scale at 4 hours post-operation ]record of postoperation pain scale at 4 hours post-operation
- change of postoperation pain scale from baseline to 6 hours post-operation [ Time Frame: Record of postoperation pain scale at 6 hours post-operation ]record of postoperation pain scale at 6 hours post-operation

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 55 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients who underwent septoplasty for septal deviation and chronic hypertrophic rhinitis
Exclusion Criteria:
- patients with comorbidities of coronary heart disease, arrhythmia, chronic obstructive lung diseases, and with past history of any nasal surgery were excluded.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01562691
Taiwan | |
Chi Mei Medical Center | |
Tainan, Taiwan, 70014 |
Study Chair: | Yung-Song Lin, M.D. | Chi Mei Medical Hospital |
Responsible Party: | Yung-Song Lin, Chairman of department of Otolaryngology, Chi Mei Medical Hospital |
ClinicalTrials.gov Identifier: | NCT01562691 |
Other Study ID Numbers: |
CMH-09706-001 |
First Posted: | March 26, 2012 Key Record Dates |
Last Update Posted: | March 26, 2012 |
Last Verified: | March 2012 |
nasal packing nasal airway septoplasty oxygen saturation postoperative pain |
Pain, Postoperative Postoperative Complications Pathologic Processes Pain |
Neurologic Manifestations Petrolatum Emollients Dermatologic Agents |